Hebei Medical University Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Shijiazhuang China (1894)

Organization Overview

First Clinical Trial
2014
NCT02555358
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Division of Liver Diseases, The Fifth Hospital of Shijiazhuang, Hebei Medical University, Shijiazhuang, Hebei Province, China | Hebei People's Hospital | Leading Principle Investigator, Division of Gastroenterology and Hepatology, NYU Langone Health, NYU School of Medicine, New York, NY, USA | Medical Ethics Committee of theThe fourth hospital of Hebei Medical University | Qun Zhao | The First Affiliated Hospital of Hebei North University | The Forth Hospital of Hebei Medical University | THE SECOND HOSPITAL TO HEBEI MEDICAL UNIVERSITY | Third Hospital of Hebei Medical University Department of Anesthesiology | xieruiqin | Xieruiqin